Addenbrooke's Charitable Trust (ACT)

Harness Therapeutics were really pleased to be part of this year’s Easter donations for the children at Addenbrooke's Charitable Trust (ACT).

A big thank you to Reed Recruitment for organising such a thoughtful initiative and to everyone who contributed. The response has been incredible, and it’s brilliant to see so many local businesses coming together.

We're glad to have played a small part in helping bring a bit of joy this Easter.

#Community #EasterGiving #Charity #Team

Our programmes

Huntington's Disease

ALS and Alzheimer's

Our news

February 2026

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board

Read more

October 2025

Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment

Read more

June 2025

Harness Therapeutics Publishes HTT CAG Repeat Sizing Methodology Code on GitHub

Read more

February 2025

Harness Therapeutics to Present Nanopore Sequencing Data for Detecting CAG Expansion in the Huntingtin Gene at CHDI Huntington’s Disease Therapeutics Conference

Read more